Toxoplasma gondii infection among chronic hepatitis C patients: a case-control study

Hala A El-Nahas1, Nora L El-Tantawy1, Raghda E Farag1

  • 1Faculty of Medicine, Mansoura University, Egypt.

Insights

Chronic hepatitis C (HCV) patients show high rates of Toxoplasma gondii (T. gondii) infection, particularly IgG antibodies. This opportunistic infection warrants consideration in HCV patient management and follow-up.

Area of Science:

  • Medical Microbiology
  • Hepatology
  • Infectious Diseases

Background:

  • Chronic hepatitis C virus (HCV) infection is a significant global health concern.
  • HCV patients may be susceptible to opportunistic infections due to altered immune status.
  • Toxoplasma gondii (T. gondii) is an opportunistic parasite with potential implications in immunocompromised individuals.

Purpose of the Study:

  • To investigate the prevalence of anti-Toxoplasma gondii (T. gondii) IgG and IgM antibodies in Egyptian patients with chronic HCV.
  • To assess the association between T. gondii infection and the stage of liver disease (cirrhosis) in HCV patients.
  • To explore correlations between T. gondii seropositivity and HCV viral load.

Main Methods:

  • Serum samples were collected from 120 chronic HCV patients (early and late-stage) and 40 healthy controls.
  • Enzyme-linked immunosorbent assay (ELISA) was used to detect anti-T. gondii IgG and IgM antibodies.
  • Real-time RT-polymerase chain reaction (RT-PCR) quantified hepatitis C virus (HCV) RNA levels.

Main Results:

  • High seropositivity rates for anti-T. gondii IgG were observed in chronic HCV patients (92.6% in late-stage, 76.9% in early-stage) compared to controls (15%).
  • Anti-T. gondii IgM antibodies showed no significant difference in prevalence across patient groups and controls.
  • A significant correlation was found between high IgG levels and higher HCV viral loads (P=0.026).

Conclusions:

  • Chronic HCV patients exhibit a high prevalence of Toxoplasma gondii IgG antibodies, suggesting increased susceptibility.
  • Opportunistic T. gondii infection poses a potential risk to chronic HCV patients, especially those with advanced liver disease.
  • Toxoplasmosis screening and management should be considered in the comprehensive care of chronic HCV patients.
Abstract

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
78
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion...
18
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
94
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.0K
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic...
30
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
23